Results 131 to 140 of about 41,395 (219)

From Phage Display to Yeast Secretion: Developing Fc-Fused Nanobodies Against Influenza Virus. [PDF]

Cells
Wang M, Li S, Li Y, Xia X, Zhang Y, Cao N, Li Y, Liu Y, Zhang S, Zhang L, Huang J.   +10 more
europepmc   +1 more source

Discovery of co-stimulatory anti-CD28 VHHs for developing cancer immune therapeutic anti-tumor/CD3/CD28 trispecific T cell engager. [PDF]

Front Immunol
Wang H, Zhao R, Liu M, Jiang T, Sun D, Chi L, Huang Y, Lu Z, Yun Y, Wang X.   +9 more
europepmc   +1 more source

Controlled immobilization of single-domain antibodies using cellulose-binding modules for AB₅-type toxin detection in paper-based assays. [PDF]

RSC Adv
Belfakir SB, Jürgensen JA, Petersson M, Wraae MS, Munk P, Thumtecho S, Masteghin MG, Ljungars A, Laustsen AH, Thrane SW, Ross GMS.   +10 more
europepmc   +1 more source

Concept: VHH i-docs

Concept for i-docs that construct (filmic) pathways through the repository.
openaire   +1 more source

Discovering novel therapeutic V_HHs for emerging viruses: perspectives from VEEV selection strategies. [PDF]

Front Immunol
LaPointe AT, Ferrara F, Zupancic JM, Montoya AL, Schmidt J, Hung LW, Kell AM, Velappan N.   +7 more
europepmc   +1 more source

Entire VHH-MMSI completed

Integration of media analytics components with the VHH Media Management and Search Infrastructure is completed and the entire VHH-MMSI is finalised.
openaire   +1 more source

Nanobody-based analysis of RhoGTPase stress response in <i>Schizosaccharomyces pombe</i>: Role of <i>mtl</i>2. [PDF]

Biotechnol Rep (Amst)
Rasheed N, Ali X, Ali T, Muhammad F, Rasheed MA.   +4 more
europepmc   +1 more source

Characterization of the VHH-Fc construct rimteravimab in healthy adults and patients hospitalized for mild-to-moderate COVID-19: Two Phase 1 randomized clinical trials. [PDF]

PLoS Med
Jansen E, Bockstal V, Herschke F, Olsson Gisleskog P, Rinaldi M, Boerboom A, Hadi S, Gaibu N, Moutschen M, Tersago D.   +9 more
europepmc   +1 more source

Balancing Multivalent Avidity and Receptor Availability Governs mRNA Delivery by Antibody-Functionalized Lipid Nanoparticles. [PDF]

Nano Lett
Hashiba K, Fukasaka M, Okuma C, Kobayashi-Ooka Y, Kajiwara K, Sugiyama A, Mizuno T, Shimomura Y, Maeda Y, Sasaki J, Enoki T, Hashino R, Mikuni S, Nishita H, Urushihara N, Ebe H, Yamada H.   +16 more
europepmc   +1 more source

Decoding antibody response to MERS-CoV in wild dromedary camels. [PDF]

Proc Natl Acad Sci U S A
Idoudi F, Wang R, Tian L, Yang Z, Chik KK, Chen P, Benabderrazek R, Fu L, Tan R, Dhaouadi S, Benlasfar Z, Somia M, Zhang Q, Shi X, Fuk-Woo Chan J, Yuen KY, Wang X, Bouhaouala-Zahar B, Zhang L.   +18 more
europepmc   +1 more source